Clinical Trials Directory

Trials / Completed

CompletedNCT03611400

The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults

The Effect of Probiotic Intake on Intestinal Permeability of Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

In this double blind, crossover study participants will take a placebo for 3 weeks each. Gut permeability will be assessed weekly using food-grade sugar molecules. On the second week, participants will take aspirin, which will make their intestine permeable to the sugars. Participants will be asked to provide urine and stool samples to assess gut permeability and microbial communities. No change in permeability to the small sugar probes is anticipated with the probiotic.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticThis probiotic is commercially available and contains L. helveticus R0052 (0.2 x 10\^9 CFU/capsule) and L. rhamnosus R0011 (3.8 x 10\^9 CFU/capsule) as active ingredients and ascorbic acid, hypromellose, magnesium stearate, saccharose, potato starch, titanium dioxide, and maltodextrin as excipients.
DIETARY_SUPPLEMENTPlaceboThe placebo contains ascorbic acid, hypromellose, magnesium stearate, saccharose, potato starch, titanium dioxide and maltodextrin.

Timeline

Start date
2018-08-22
Primary completion
2019-04-15
Completion
2019-04-15
First posted
2018-08-02
Last updated
2019-06-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03611400. Inclusion in this directory is not an endorsement.